4
MARKET OVERVIEW
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
4.3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
5.1
PORTER'S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN US WOUND CARE INDUSTRY
5.5.1
AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS, BY KEY PLAYER, 2024-2026
5.5.2
AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS, BY TYPE, 2024-2026
5.7
KEY CONFERENCES AND EVENTS (2026-2027)
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.10
IMPACT OF 2025 US TARIFF ON US WOUND CARE MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON END-USE INDUSTRIES
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.5
IMPACT OF AI/GEN AI ON US WOUND CARE MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
CASE STUDIES OF AI IMPLEMENTATION
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOUR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
US WOUND CARE MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
9.2
ADVANCED WOUND CARE PRODUCTS
9.2.1
ADVANCED WOUND DRESSINGS, BY TYPE
9.2.1.1.1
SILICON FOAM DRESSINGS
9.2.1.1.2
NON-SILICON FOAM DRESSINGS
9.2.1.2
HYDROCOLLOID DRESSINGS
9.2.1.4
ALGINATE DRESSINGS
9.2.1.5
HYDROGEL DRESSINGS
9.2.1.6
COLLAGEN DRESSINGS
9.2.1.7
HYDROFIBER DRESSINGS
9.2.1.8
WOUND CONTACT LAYERS
9.2.1.9
SUPERABSORBENT DRESSINGS
9.2.1.10
OTHER ADVANCED WOUND CARE DRESSINGS
9.2.2
ADVANCED WOUND DRESSINGS, BY PROPERTY
9.2.2.1
NON-ANTIMICROBIAL DRESSINGS
9.2.2.2
ANTIMICROBIAL DRESSINGS
9.2.3
DEVICES & ACCESSORIES
9.2.3.1
NPWT DEVICES & ACCESSORIES
9.2.3.2
DEBRIDEMENT DEVICES & ACCESSORIES
9.2.3.3
WOUND ASSESSMENT & MONITORING DEVICES
9.2.3.4
OTHER DEVICES & ACCESSORIES
9.2.4
BIOLOGICAL SKIN SUBSTITUTES
9.2.4.1
HUMAN DONOR TISSUE-DERIVED PRODUCTS
9.2.4.2
ACELLULAR ANIMAL-DERIVED PRODUCTS
9.2.4.3
BIOSYNTHETIC PRODUCTS
9
.3 SURGICAL WOUND CARE PRODUCTS
9.3.2
TISSUE ADHESIVES, SEALANTS, AND GLUES
9.3.2.1
FIBRIN-BASED SEALANTS
9.3.2.2
SYNTHETIC ADHESIVES
9.3.2.3
COLLAGEN-BASED SEALANTS
9.4
TRADITIONAL WOUND CARE PRODUCTS
9.4.8
OTHER TRADITIONAL WOUND CARE PRODUCTS
10
US WOUND CARES MARKET, BY WOUND TYPE (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
10.2.1
DIABETIC FOOT ULCERS
10.2.4
OTHER CHRONIC WOUNDS
10.3.1
SURGICAL & TRAUMATIC WOUNDS
11
US WOUND CARES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
11.2.1
DIABETIC FOOT ULCERS
11.4
LONG-TERM CARE FACILITIES
12
US WOUND CARE MARKET, COMPETITIVE LANDSCAPE
12.2
KEY PLAYER STRATEGIES/RIGHT-TO-WIN
12.3
REVENUE ANALYSIS, 2021–2025
12.4
MARKET SHARE ANALYSIS,
12.5
COMPANY VALUATION & FINANCIAL METRICS
12.6
BRAND/PRODUCT COMPARISON
12.7
COMPANY EVALUATION MATRIX: KEY PLAYERS,
12.7.5
COMPANY FOOTPRINT: KEY PLAYERS,
12.7.5.1
COMPANY FOOTPRINT
12.7.5.2
PRODUCT FOOTPRINT
12.7.5.3
WOUND TYPE FOOTPRINT
12.7.5.4
END USER FOOTPRINT
12.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
12.8.1
PROGRESSIVE COMPANIES
12.8.2
RESPONSIVE COMPANIES
12.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
12.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
12.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
12.9
COMPETITIVE SITUATION AND TRENDS
13
US WOUND CARE MARKET, COMPANY PROFILES
13.1.2
JOHNSON & JOHNSON SERVICES, INC. (ETHICON)
13.1.6
CONVATEC GROUP PLC
13.1.8
ORGANOGENESIS INC.
13.1.10
MIMEDEX GROUP, INC.
13.1.13
ESSITY AKTIEBOLAG
13.1.14
INTEGRA LIFESCIENCES CORPORATION
13.1.15
AVERY DENNISON CORPORATION
13.1.16
MATIV HOLDINGS, INC.
13.2.1
LOHMANN & RAUSHER GMBH & CO.KG
13.2.2
MEDLINE INDUSTRIES
13.2.3
WINNER MEDICAL CO., LTD.
13.2.5
DIRECT HEALTHCARE GROUP
14.2.1.1
KEY DATA FROM SECONDARY SOURCES
14.2.3
MARKET SIZE ESTIMATION
14.2.3.1
BOTTOM-UP APPROACH
14.2.3.2
TOP-DOWN APPROACH
14.2.3.3
BASE NUMBER CALCULATION
14.2.4
MARKET FORECAST APPROACH
14.2.5
DATA TRIANGULATION
14.2.8
RESEARCH LIMITATIONS AND RISK ASSESSMENT
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in US Wound Care Market